Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biphenotypic acute leukemia with t(15;17).
Scolnik MP, Aranguren PN, Cuello MT, Palacios MF, Sanjurjo J, Giunta M, Bracco MM, Acevedo S. Scolnik MP, et al. Among authors: aranguren pn. Leuk Lymphoma. 2005 Apr;46(4):607-10. doi: 10.1080/10428190412331272730. Leuk Lymphoma. 2005. PMID: 16019491
Immune checkpoints PD1/PDL1, TIM3/GAL9 and key immune mediators landscape reveal differential expression dynamics on imatinib response in chronic myeloid leukemia.
Toloza MJ, Lincango M, Camacho MF, Ledesma MM, Enrico A, Moiraghi B, Tosin F, Mariano R, Pérez M, Aranguren PN, Riva ME, Larripa IB, Belli CB. Toloza MJ, et al. Among authors: aranguren pn. Ann Hematol. 2024 Dec;103(12):5249-5260. doi: 10.1007/s00277-024-06074-3. Epub 2024 Nov 7. Ann Hematol. 2024. PMID: 39505795
Molecular monitoring of imatinib in chronic myeloid leukemia patients in complete cytogenetic remission: does achievement of a stable major molecular response at any time point identify a privileged group of patients? A multicenter experience in Argentina and Uruguay.
Pavlovsky C, Giere I, Moiraghi B, Pavlovsky MA, Aranguren PN, García J, Fernandez I, Bengió R, Milone J, Labanca V, Uriarte R, Lombardi V, Reinoso FG, Magariños AE, Martinez L, Murro H, Lastiri F, Pavlovsky S. Pavlovsky C, et al. Among authors: aranguren pn. Clin Lymphoma Myeloma Leuk. 2011 Jun;11(3):280-5. doi: 10.1016/j.clml.2011.03.016. Epub 2011 Apr 20. Clin Lymphoma Myeloma Leuk. 2011. PMID: 21658656 Clinical Trial.
Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's disease.
Pavlovsky S, Schvartzman E, Lastiri F, Magnasco H, Corrado C, Raslawski E, Cancela ME, Ardaiz MC, Cerutti I, Rosso A, Bruno S, Aranguren PN, Salvarezza A, Donato H, Dibar E, Zirone S. Pavlovsky S, et al. Among authors: aranguren pn. J Clin Oncol. 1997 Jul;15(7):2652-8. doi: 10.1200/JCO.1997.15.7.2652. J Clin Oncol. 1997. PMID: 9215837 Clinical Trial.
PH negative acute lymphoblastic leukemia in adolescents and young adults treated according a MRD adapted BFM ALL IC 2009 protocol: Argentine real-world data on 171 patients.
Ferrari LC, Rivas MM, Navickas AB, Dick H, Mela Osorio MJ, Agamennoni L, Rey IH, Carnelutto NE, Cazap N, Castro MB, Aranguren PN, Fischman LA, Yupanki ML, Milone JH, Fernández II, Moirano MM, Belli CB; Grupo Argentino de Leucemias Agudas (GALA) and Grupo Argentino de Tratamiento de Leucemias Agudas (GATLA). Ferrari LC, et al. Among authors: aranguren pn. Ann Hematol. 2023 May;102(5):1087-1097. doi: 10.1007/s00277-023-05151-3. Epub 2023 Mar 9. Ann Hematol. 2023. PMID: 36892593